A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Billions of doses of COVID-19 vaccines have been administered globally, dramatically
reducing SARS-CoV-2 incidence and severity in some settings. Many studies suggest …
reducing SARS-CoV-2 incidence and severity in some settings. Many studies suggest …
Covid-19 vaccines, immunity, and boosters
A Richterman, J Scott, M Cevik - Bmj, 2021 - bmj.com
Since our previous editorial in September 2021, 1 a growing body of evidence about covid-
19 vaccine effectiveness, including that of third and booster doses, has been published, and …
19 vaccine effectiveness, including that of third and booster doses, has been published, and …
[PDF][PDF] Interim recommendations for heterologous COVID-19 vaccine schedules: interim guidance, 16 December 2021
World Health Organization - 2021 - apps.who.int
Interim recommendations for heterologous COVID-19 vaccine schedules Page 1 -1- Interim
recommendations for heterologous COVID-19 vaccine schedules Interim guidance 16 December …
recommendations for heterologous COVID-19 vaccine schedules Interim guidance 16 December …
[PDF][PDF] Analysis of anti-Omicron neutralizing antibody titers in different convalescent plasma sources
Analysis of anti-Omicron neutralizing antibody titers in different convalescent plasma sources
Page 1 1 Analysis of anti-Omicron neutralizing antibody titers in different convalescent plasma …
Page 1 1 Analysis of anti-Omicron neutralizing antibody titers in different convalescent plasma …
COVID-19 endgame: from pandemic to endemic? Vaccination, reopening and evolution in a well-vaccinated population
COVID-19 remains a major public health concern, with large resurgences even where there
has been widespread uptake of vaccines. Waning immunity and the emergence of new …
has been widespread uptake of vaccines. Waning immunity and the emergence of new …
[PDF][PDF] Wissenschaftliche Begründung der STIKO zur Aktualisierung der Empfehlung der COVID-19-Auffrischimpfung mit einem mRNA-Impfstoff
J Koch, S Vygen-Bonnet, C Bogdan, G Burchard… - 2021 - edoc.rki.de
Epidemiologisches Bulletin 48/2021 Page 1 Wissenschaftliche Begründung der STIKO zur
Aktualisierung der Empfehlung der COVID-19-Auffrischimpfung mit einem mRNA-Impfstoff 1 …
Aktualisierung der Empfehlung der COVID-19-Auffrischimpfung mit einem mRNA-Impfstoff 1 …
[PDF][PDF] COVID-19 Evidence Support Team RAPID REVIEW REPORT
M Jagwani - 2021 - saskhealthauthority.ca
COVID-19 Evidence Support Team RAPID REVIEW REPORT Updated Key Findings Key
Findings How effective are COVID-19 vaccines? Page 1 Rapid Review Report: INF031801v013 …
Findings How effective are COVID-19 vaccines? Page 1 Rapid Review Report: INF031801v013 …
[PDF][PDF] Change in the level of vaccine protection over time in COVID-19 vaccinated individuals
Background To date in Canada, four vaccines have been approved to prevent coronavirus
disease 2019 (COVID-19). While their short-term (< 4 months) effectiveness in preventing …
disease 2019 (COVID-19). While their short-term (< 4 months) effectiveness in preventing …
COVID-19 Weekly Epidemiological Update
W Pacific - Americas - JSTOR
Global case and death incidences continued to decrease with over 3 million new weekly
cases and over 73 000 new deaths, a 15% and an 8% decrease respectively, compared to …
cases and over 73 000 new deaths, a 15% and an 8% decrease respectively, compared to …
[引用][C] Liebe Kolleginnen und Kollegen, im Anhang übersenden wir Ihnen noch das aktuelle Impfbulletin der STIKO zum Procedere bei Coronaimpfungen. Besonders …
M ganz persönliche Meinung